Structure

Physi-Chem Properties

Molecular Weight:  318.22
Volume:  341.348
LogP:  2.024
LogD:  2.342
LogS:  -3.17
# Rotatable Bonds:  1
TPSA:  57.53
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.731
Synthetic Accessibility Score:  5.832
Fsp3:  0.85
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.675
MDCK Permeability:  2.5299805201939307e-05
Pgp-inhibitor:  0.061
Pgp-substrate:  0.023
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.908
30% Bioavailability (F30%):  0.315

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.7
Plasma Protein Binding (PPB):  51.0046501159668%
Volume Distribution (VD):  0.755
Pgp-substrate:  42.34280776977539%

ADMET: Metabolism

CYP1A2-inhibitor:  0.048
CYP1A2-substrate:  0.349
CYP2C19-inhibitor:  0.021
CYP2C19-substrate:  0.691
CYP2C9-inhibitor:  0.055
CYP2C9-substrate:  0.047
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.104
CYP3A4-inhibitor:  0.809
CYP3A4-substrate:  0.249

ADMET: Excretion

Clearance (CL):  8.853
Half-life (T1/2):  0.318

ADMET: Toxicity

hERG Blockers:  0.194
Human Hepatotoxicity (H-HT):  0.142
Drug-inuced Liver Injury (DILI):  0.058
AMES Toxicity:  0.064
Rat Oral Acute Toxicity:  0.983
Maximum Recommended Daily Dose:  0.984
Skin Sensitization:  0.951
Carcinogencity:  0.849
Eye Corrosion:  0.455
Eye Irritation:  0.359
Respiratory Toxicity:  0.984

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471034

Natural Product ID:  NPC471034
Common Name*:   PHXVQRJHPRPGAN-XVLAHQNTSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  PHXVQRJHPRPGAN-XVLAHQNTSA-N
Standard InCHI:  InChI=1S/C20H30O3/c1-12-13-5-6-14-19(3)8-4-7-18(2,11-21)15(19)9-16(22)20(14,10-13)17(12)23/h13-16,21-22H,1,4-11H2,2-3H3/t13-,14-,15+,16-,18+,19-,20+/m0/s1
SMILES:  OC[C@@]1(C)CCC[C@@]2([C@@H]1C[C@H](O)[C@]13[C@H]2CC[C@@H](C1)C(=C)C3=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2337571
PubChem CID:   71720768
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[14510600]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[18161942]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. Vietnamese n.a. PMID[19899773]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22085418]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. leaf n.a. PMID[22085418]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[22197145]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota whole plants Vietnam 2009-Aug PMID[23347584]
NPO22879 Croton tonkinensis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition = 45.77 % PMID[501688]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 3950.0 nM PMID[501688]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471034 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC190704
0.9753 High Similarity NPC259009
0.9747 High Similarity NPC471036
0.9747 High Similarity NPC291320
0.9405 High Similarity NPC261994
0.9405 High Similarity NPC470378
0.9405 High Similarity NPC149761
0.9405 High Similarity NPC80401
0.9294 High Similarity NPC299185
0.9294 High Similarity NPC211403
0.9294 High Similarity NPC198242
0.9294 High Similarity NPC476168
0.9277 High Similarity NPC165895
0.9277 High Similarity NPC153604
0.9268 High Similarity NPC102292
0.9186 High Similarity NPC144739
0.9186 High Similarity NPC181594
0.9146 High Similarity NPC146683
0.9136 High Similarity NPC110780
0.908 High Similarity NPC261333
0.908 High Similarity NPC91772
0.908 High Similarity NPC29247
0.908 High Similarity NPC289539
0.908 High Similarity NPC129004
0.908 High Similarity NPC64006
0.908 High Similarity NPC215271
0.908 High Similarity NPC191094
0.908 High Similarity NPC153775
0.908 High Similarity NPC104371
0.908 High Similarity NPC302008
0.908 High Similarity NPC47853
0.908 High Similarity NPC111524
0.908 High Similarity NPC292374
0.908 High Similarity NPC470385
0.908 High Similarity NPC101233
0.908 High Similarity NPC470386
0.9036 High Similarity NPC76518
0.9024 High Similarity NPC118800
0.8987 High Similarity NPC106078
0.8977 High Similarity NPC231060
0.8977 High Similarity NPC470232
0.8977 High Similarity NPC84018
0.8977 High Similarity NPC138245
0.8953 High Similarity NPC180849
0.8876 High Similarity NPC135548
0.8876 High Similarity NPC264979
0.8876 High Similarity NPC140242
0.8876 High Similarity NPC470387
0.8876 High Similarity NPC329910
0.8864 High Similarity NPC475118
0.8824 High Similarity NPC57469
0.8824 High Similarity NPC174619
0.8795 High Similarity NPC475726
0.8795 High Similarity NPC472743
0.8764 High Similarity NPC470229
0.875 High Similarity NPC59170
0.875 High Similarity NPC59350
0.8721 High Similarity NPC193360
0.8721 High Similarity NPC471724
0.8721 High Similarity NPC472739
0.8706 High Similarity NPC98236
0.8706 High Similarity NPC269396
0.869 High Similarity NPC475745
0.869 High Similarity NPC474482
0.8681 High Similarity NPC16911
0.8681 High Similarity NPC78427
0.8681 High Similarity NPC471038
0.8675 High Similarity NPC46881
0.8636 High Similarity NPC278106
0.8636 High Similarity NPC250753
0.8621 High Similarity NPC471043
0.8588 High Similarity NPC292553
0.8587 High Similarity NPC156324
0.8587 High Similarity NPC55503
0.8587 High Similarity NPC127408
0.8587 High Similarity NPC287676
0.8587 High Similarity NPC470388
0.8587 High Similarity NPC291785
0.8556 High Similarity NPC98639
0.8556 High Similarity NPC210214
0.8556 High Similarity NPC29112
0.8539 High Similarity NPC82138
0.8523 High Similarity NPC46758
0.8523 High Similarity NPC100313
0.8523 High Similarity NPC126993
0.8506 High Similarity NPC146937
0.8506 High Similarity NPC471900
0.8495 Intermediate Similarity NPC52899
0.8495 Intermediate Similarity NPC289148
0.8495 Intermediate Similarity NPC71706
0.8495 Intermediate Similarity NPC471790
0.8495 Intermediate Similarity NPC46848
0.8495 Intermediate Similarity NPC163963
0.8488 Intermediate Similarity NPC472738
0.8478 Intermediate Similarity NPC474793
0.8471 Intermediate Similarity NPC74595
0.8471 Intermediate Similarity NPC474233
0.8471 Intermediate Similarity NPC264665
0.8462 Intermediate Similarity NPC200054
0.8462 Intermediate Similarity NPC13949
0.8462 Intermediate Similarity NPC29410
0.8434 Intermediate Similarity NPC164999
0.8427 Intermediate Similarity NPC470230
0.8427 Intermediate Similarity NPC272746
0.8409 Intermediate Similarity NPC213832
0.8409 Intermediate Similarity NPC57954
0.8404 Intermediate Similarity NPC148628
0.8404 Intermediate Similarity NPC286519
0.8404 Intermediate Similarity NPC309388
0.8404 Intermediate Similarity NPC88203
0.8404 Intermediate Similarity NPC475803
0.8404 Intermediate Similarity NPC272472
0.8404 Intermediate Similarity NPC246736
0.8404 Intermediate Similarity NPC304832
0.8404 Intermediate Similarity NPC214946
0.8404 Intermediate Similarity NPC275990
0.8404 Intermediate Similarity NPC76866
0.8391 Intermediate Similarity NPC472495
0.8391 Intermediate Similarity NPC4643
0.8391 Intermediate Similarity NPC472497
0.8375 Intermediate Similarity NPC308440
0.8375 Intermediate Similarity NPC472503
0.8372 Intermediate Similarity NPC264317
0.8372 Intermediate Similarity NPC294438
0.837 Intermediate Similarity NPC170978
0.837 Intermediate Similarity NPC10864
0.8353 Intermediate Similarity NPC175410
0.8352 Intermediate Similarity NPC41070
0.8352 Intermediate Similarity NPC288906
0.8352 Intermediate Similarity NPC263135
0.8333 Intermediate Similarity NPC244356
0.8333 Intermediate Similarity NPC294263
0.8333 Intermediate Similarity NPC224060
0.8333 Intermediate Similarity NPC328264
0.8316 Intermediate Similarity NPC209298
0.8316 Intermediate Similarity NPC87927
0.8316 Intermediate Similarity NPC139347
0.8316 Intermediate Similarity NPC122811
0.8316 Intermediate Similarity NPC277074
0.8316 Intermediate Similarity NPC216114
0.8315 Intermediate Similarity NPC85173
0.8315 Intermediate Similarity NPC169933
0.8313 Intermediate Similarity NPC201459
0.8298 Intermediate Similarity NPC236585
0.8298 Intermediate Similarity NPC14634
0.8295 Intermediate Similarity NPC474719
0.8295 Intermediate Similarity NPC474677
0.8295 Intermediate Similarity NPC328539
0.8293 Intermediate Similarity NPC149249
0.8293 Intermediate Similarity NPC212661
0.8293 Intermediate Similarity NPC471035
0.8293 Intermediate Similarity NPC472746
0.828 Intermediate Similarity NPC162459
0.828 Intermediate Similarity NPC38296
0.828 Intermediate Similarity NPC89099
0.828 Intermediate Similarity NPC38471
0.828 Intermediate Similarity NPC109059
0.828 Intermediate Similarity NPC288
0.828 Intermediate Similarity NPC20479
0.828 Intermediate Similarity NPC98837
0.828 Intermediate Similarity NPC28864
0.8276 Intermediate Similarity NPC12774
0.8276 Intermediate Similarity NPC72133
0.8276 Intermediate Similarity NPC2783
0.8276 Intermediate Similarity NPC34190
0.8261 Intermediate Similarity NPC234564
0.8242 Intermediate Similarity NPC196485
0.8242 Intermediate Similarity NPC471207
0.8242 Intermediate Similarity NPC209662
0.8242 Intermediate Similarity NPC245972
0.8242 Intermediate Similarity NPC280804
0.8242 Intermediate Similarity NPC111015
0.8235 Intermediate Similarity NPC477858
0.8235 Intermediate Similarity NPC145143
0.8229 Intermediate Similarity NPC13149
0.8229 Intermediate Similarity NPC98603
0.8229 Intermediate Similarity NPC84928
0.8222 Intermediate Similarity NPC233116
0.8222 Intermediate Similarity NPC475416
0.8222 Intermediate Similarity NPC131872
0.8214 Intermediate Similarity NPC472478
0.8202 Intermediate Similarity NPC186688
0.8202 Intermediate Similarity NPC119416
0.8191 Intermediate Similarity NPC293866
0.8191 Intermediate Similarity NPC267921
0.8182 Intermediate Similarity NPC475740
0.8182 Intermediate Similarity NPC264005
0.8182 Intermediate Similarity NPC33768
0.8182 Intermediate Similarity NPC269360
0.8182 Intermediate Similarity NPC298904
0.8172 Intermediate Similarity NPC108078
0.8172 Intermediate Similarity NPC253586
0.8161 Intermediate Similarity NPC470574
0.8161 Intermediate Similarity NPC201655
0.8152 Intermediate Similarity NPC266431
0.8152 Intermediate Similarity NPC472485
0.8152 Intermediate Similarity NPC271195
0.8144 Intermediate Similarity NPC4115
0.8144 Intermediate Similarity NPC12823
0.8144 Intermediate Similarity NPC200957

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471034 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8372 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD4788 Approved
0.8276 Intermediate Similarity NPD3618 Phase 1
0.8222 Intermediate Similarity NPD6079 Approved
0.8202 Intermediate Similarity NPD5328 Approved
0.8049 Intermediate Similarity NPD3703 Phase 2
0.8046 Intermediate Similarity NPD4786 Approved
0.8023 Intermediate Similarity NPD3667 Approved
0.7935 Intermediate Similarity NPD4202 Approved
0.7901 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD5222 Approved
0.7872 Intermediate Similarity NPD5221 Approved
0.7841 Intermediate Similarity NPD3665 Phase 1
0.7841 Intermediate Similarity NPD3133 Approved
0.7841 Intermediate Similarity NPD3666 Approved
0.7789 Intermediate Similarity NPD5173 Approved
0.7765 Intermediate Similarity NPD6697 Approved
0.7765 Intermediate Similarity NPD6114 Approved
0.7765 Intermediate Similarity NPD6118 Approved
0.7765 Intermediate Similarity NPD6115 Approved
0.7684 Intermediate Similarity NPD4697 Phase 3
0.7667 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD4634 Approved
0.7634 Intermediate Similarity NPD8034 Phase 2
0.7634 Intermediate Similarity NPD7515 Phase 2
0.7634 Intermediate Similarity NPD8035 Phase 2
0.7629 Intermediate Similarity NPD5286 Approved
0.7629 Intermediate Similarity NPD4696 Approved
0.7629 Intermediate Similarity NPD5285 Approved
0.7604 Intermediate Similarity NPD4755 Approved
0.7551 Intermediate Similarity NPD5223 Approved
0.7529 Intermediate Similarity NPD6117 Approved
0.75 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7475 Intermediate Similarity NPD5226 Approved
0.7475 Intermediate Similarity NPD5224 Approved
0.7475 Intermediate Similarity NPD4633 Approved
0.7475 Intermediate Similarity NPD5211 Phase 2
0.7475 Intermediate Similarity NPD5225 Approved
0.7473 Intermediate Similarity NPD5279 Phase 3
0.7449 Intermediate Similarity NPD4700 Approved
0.7442 Intermediate Similarity NPD6116 Phase 1
0.7439 Intermediate Similarity NPD3698 Phase 2
0.7419 Intermediate Similarity NPD4753 Phase 2
0.7416 Intermediate Similarity NPD4223 Phase 3
0.7416 Intermediate Similarity NPD4221 Approved
0.74 Intermediate Similarity NPD5175 Approved
0.74 Intermediate Similarity NPD5174 Approved
0.7386 Intermediate Similarity NPD7525 Registered
0.7375 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD4789 Approved
0.7349 Intermediate Similarity NPD4245 Approved
0.7349 Intermediate Similarity NPD4244 Approved
0.7347 Intermediate Similarity NPD7638 Approved
0.7327 Intermediate Similarity NPD5141 Approved
0.7317 Intermediate Similarity NPD5360 Phase 3
0.7317 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD7748 Approved
0.7273 Intermediate Similarity NPD7640 Approved
0.7273 Intermediate Similarity NPD7639 Approved
0.7253 Intermediate Similarity NPD4197 Approved
0.7253 Intermediate Similarity NPD3668 Phase 3
0.7228 Intermediate Similarity NPD4754 Approved
0.7216 Intermediate Similarity NPD4629 Approved
0.7216 Intermediate Similarity NPD5210 Approved
0.7188 Intermediate Similarity NPD6399 Phase 3
0.7184 Intermediate Similarity NPD5697 Approved
0.7174 Intermediate Similarity NPD5329 Approved
0.7159 Intermediate Similarity NPD3671 Phase 1
0.7159 Intermediate Similarity NPD3617 Approved
0.7115 Intermediate Similarity NPD6899 Approved
0.7115 Intermediate Similarity NPD6881 Approved
0.7115 Intermediate Similarity NPD4729 Approved
0.7115 Intermediate Similarity NPD6011 Approved
0.7115 Intermediate Similarity NPD4730 Approved
0.7115 Intermediate Similarity NPD5128 Approved
0.7115 Intermediate Similarity NPD5168 Approved
0.7103 Intermediate Similarity NPD4632 Approved
0.7097 Intermediate Similarity NPD5205 Approved
0.7097 Intermediate Similarity NPD4693 Phase 3
0.7097 Intermediate Similarity NPD4690 Approved
0.7097 Intermediate Similarity NPD5690 Phase 2
0.7097 Intermediate Similarity NPD4688 Approved
0.7097 Intermediate Similarity NPD4689 Approved
0.7097 Intermediate Similarity NPD4138 Approved
0.7087 Intermediate Similarity NPD6402 Approved
0.7087 Intermediate Similarity NPD4768 Approved
0.7087 Intermediate Similarity NPD5739 Approved
0.7087 Intermediate Similarity NPD7128 Approved
0.7087 Intermediate Similarity NPD4767 Approved
0.7087 Intermediate Similarity NPD6675 Approved
0.7073 Intermediate Similarity NPD4224 Phase 2
0.7071 Intermediate Similarity NPD7902 Approved
0.7059 Intermediate Similarity NPD4758 Discontinued
0.7048 Intermediate Similarity NPD6014 Approved
0.7048 Intermediate Similarity NPD6012 Approved
0.7048 Intermediate Similarity NPD6013 Approved
0.7027 Intermediate Similarity NPD6054 Approved
0.7027 Intermediate Similarity NPD6319 Approved
0.7019 Intermediate Similarity NPD5701 Approved
0.7011 Intermediate Similarity NPD7339 Approved
0.7011 Intermediate Similarity NPD6942 Approved
0.7 Intermediate Similarity NPD4695 Discontinued
0.6981 Remote Similarity NPD5169 Approved
0.6981 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6981 Remote Similarity NPD5248 Approved
0.6981 Remote Similarity NPD7290 Approved
0.6981 Remote Similarity NPD5250 Approved
0.6981 Remote Similarity NPD6883 Approved
0.6981 Remote Similarity NPD5247 Approved
0.6981 Remote Similarity NPD5135 Approved
0.6981 Remote Similarity NPD5251 Approved
0.6981 Remote Similarity NPD7102 Approved
0.6981 Remote Similarity NPD5249 Phase 3
0.6964 Remote Similarity NPD6016 Approved
0.6964 Remote Similarity NPD6015 Approved
0.6952 Remote Similarity NPD7320 Approved
0.6947 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6932 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6916 Remote Similarity NPD6650 Approved
0.6916 Remote Similarity NPD8130 Phase 1
0.6916 Remote Similarity NPD5127 Approved
0.6916 Remote Similarity NPD5215 Approved
0.6916 Remote Similarity NPD6617 Approved
0.6916 Remote Similarity NPD5216 Approved
0.6916 Remote Similarity NPD6869 Approved
0.6916 Remote Similarity NPD5217 Approved
0.6916 Remote Similarity NPD6649 Approved
0.6916 Remote Similarity NPD6847 Approved
0.6915 Remote Similarity NPD5280 Approved
0.6915 Remote Similarity NPD7334 Approved
0.6915 Remote Similarity NPD6409 Approved
0.6915 Remote Similarity NPD6684 Approved
0.6915 Remote Similarity NPD7146 Approved
0.6915 Remote Similarity NPD7521 Approved
0.6915 Remote Similarity NPD5330 Approved
0.6915 Remote Similarity NPD4694 Approved
0.6909 Remote Similarity NPD6009 Approved
0.6909 Remote Similarity NPD7115 Discovery
0.6903 Remote Similarity NPD6370 Approved
0.6903 Remote Similarity NPD5988 Approved
0.69 Remote Similarity NPD6083 Phase 2
0.69 Remote Similarity NPD6084 Phase 2
0.6889 Remote Similarity NPD7645 Phase 2
0.6889 Remote Similarity NPD4195 Approved
0.6887 Remote Similarity NPD6372 Approved
0.6887 Remote Similarity NPD6373 Approved
0.6875 Remote Similarity NPD6059 Approved
0.6852 Remote Similarity NPD6882 Approved
0.6852 Remote Similarity NPD8297 Approved
0.6796 Remote Similarity NPD7632 Discontinued
0.6783 Remote Similarity NPD7492 Approved
0.6771 Remote Similarity NPD6903 Approved
0.6771 Remote Similarity NPD6672 Approved
0.6771 Remote Similarity NPD5737 Approved
0.6768 Remote Similarity NPD7900 Approved
0.6768 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6762 Remote Similarity NPD6008 Approved
0.6759 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6752 Remote Similarity NPD7736 Approved
0.6744 Remote Similarity NPD4747 Approved
0.6744 Remote Similarity NPD4691 Approved
0.6739 Remote Similarity NPD4692 Approved
0.6739 Remote Similarity NPD4139 Approved
0.6737 Remote Similarity NPD4623 Approved
0.6737 Remote Similarity NPD4519 Discontinued
0.6727 Remote Similarity NPD5167 Approved
0.6724 Remote Similarity NPD6616 Approved
0.67 Remote Similarity NPD5695 Phase 3
0.6698 Remote Similarity NPD6412 Phase 2
0.6667 Remote Similarity NPD6081 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD4225 Approved
0.6667 Remote Similarity NPD5290 Discontinued
0.6667 Remote Similarity NPD5983 Phase 2
0.6667 Remote Similarity NPD6274 Approved
0.6667 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5696 Approved
0.6667 Remote Similarity NPD7078 Approved
0.6667 Remote Similarity NPD3573 Approved
0.6637 Remote Similarity NPD4522 Approved
0.6636 Remote Similarity NPD8133 Approved
0.6636 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6628 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6628 Remote Similarity NPD4137 Phase 3
0.6607 Remote Similarity NPD6317 Approved
0.6593 Remote Similarity NPD5364 Discontinued
0.6566 Remote Similarity NPD5284 Approved
0.6566 Remote Similarity NPD5281 Approved
0.6552 Remote Similarity NPD7604 Phase 2
0.6549 Remote Similarity NPD6335 Approved
0.6549 Remote Similarity NPD6313 Approved
0.6549 Remote Similarity NPD6314 Approved
0.6535 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6525 Remote Similarity NPD8293 Discontinued
0.6522 Remote Similarity NPD6929 Approved
0.6517 Remote Similarity NPD4058 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data